Response to vaccination against hepatitis B virus with a schedule of four 40-μg doses in cirrhotic patients evaluated for liver transplantation: Factors associated with a response

Transplantation Proceedings

Volumn 44, Issue 6, 2012, Pages 1499-1501

  Gutierrez Domingo, I ^a   Pascasio Acevedo, J M ^a   Alcalde Vargas, A ^a   Ramos Cuadra, A ^a   Ferrer Rios M T ^a   Sousa Martin, J M ^a   Sayago Mota, M ^a   Giraldez Gallego A ^a   Suarez Artacho G ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGED; BODY MASS; CONFERENCE PAPER; CONTROLLED STUDY; EVALUATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVACCINATION; SMOKING; TREATMENT RESPONSE; VACCINATION;

ADOLESCENT; ADULT; AGED; CHI-SQUARE DISTRIBUTION; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION SCHEDULE; INJECTIONS, INTRAMUSCULAR; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPAIN; TIME FACTORS; TREATMENT OUTCOME; VACCINATION; YOUNG ADULT;

EID: 84864398732     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.05.071     Document Type: Conference Paper

References (16)

1. D. Samuel, X. Forns, M. Berenguer Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis J Hepatol 45 2006 127
2. C.K. Hui, W.W.W. Cheung, S.C. Chan Hepatitis B vaccination and preemptive treatment of hepatitis B virus in liver transplantation Curr Opin Organ Transplant 11 2006 594
3. G. Reiss, E.B. Keefe Review article: hepatitis vaccination in patients with chronic liver disease Aliment Pharmacol Ther 19 2004 715
4. N. Chalasani, G. Smallwood, J. Halcomb Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation? Liver Transpl Surg 4 1998 128
5. C. Mendenhall, G.A. Roselle, L.A. Lybecker Hepatitis B vaccination: response of alcoholics with and without liver injury Dig Dis Sci 33 1988 263
6. W. Carey, R. Pimentel, M.K. Westveer Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial Am J Gastroenterol 85 1990 1590
7. J. Berner, M. Kadian, J. Post Prophylactic recombinant hepatitis B vaccine in patients undergoing orthotopic liver transplantation Transplant Proc 25 1993 1751
8. D.H. Van Thiel, L. El-Ashmawy, K. Love Response to hepatitis B vaccination by liver transplant candidates Dig Dis Sci 37 1992 1245
9. C. Loinaz, J.R. De Juanes, E. Moreno González Hepatitis B vaccination results in 140 liver transplant recipients Hepatogastroenterology 44 1997 235
10. G. Clemente Ricote, F. Pérez Roldán, R. Bañares Cañizares Respuesta a la vacuna de la hepatitis B previa al trasplante hepático ortotópico Rev Esp Enferm Dig 87 1995 516
11. M. Domínguez, R. Bárcena, M. Garcia Vaccination against hepatitis B virus in cirrhotic patients on liver transplant waiting list Liver Transpl 6 2000 440
12. B. Kallinowski, C. Benz, L. Bucholz Accelerated schedule of hepatitis B vaccination in liver transplant candidates Transplant Proc 30 1998 797
13. S.H. Engler, P.W. Sauer, M. Golling Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates Eur J Gastroenterol Hepatol 13 2001 363
14. T. De Artaza, J.J. Sánchez-Ruano, A. García-Vela Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease Gastroenterol Hepatol 32 2009 403
15. M. Arslan, R.H. Wiesner, C. Sievers Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease Liver Transpl 7 2001 314
16. D.S. Chen Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B J Hepatol 50 2009 805